Open AccessOR29-5 Phase 3 PaTHway Trial: Participants Treated With TransCon PTH Achieved Independence From Conventional Therapy While Maintaining Normal Serum Calcium
Author(s) -
Aliya Khan
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.1661
Subject(s) - medicine , placebo , alfacalcidol , clinical endpoint , vitamin d and neurology , randomization , calcium , calcitriol , gastroenterology , parathyroid hormone , randomized controlled trial , urology , endocrinology , osteoporosis , bone mineral , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom